## Core Concept
The question tests the understanding of properties of topical beta blockers used in ophthalmology, specifically for the treatment of glaucoma. Topical beta blockers decrease intraocular pressure (IOP) by reducing the production of aqueous humor. The ideal properties of a topical beta blocker for ophthalmic use include high lipid solubility, cardioselectivity, and a long duration of action.

## Why the Correct Answer is Right
The correct answer, , is likely related to a property that is not desirable or not characteristic of an ideal topical beta blocker for ophthalmic use. Topical beta blockers like timolol, betaxolol, and levobunolol are used. These drugs are chosen for their ability to decrease IOP with minimal systemic side effects. A drug with high water solubility (hydrophilicity) would be less ideal because it would be less likely to cross the corneal barrier, potentially reducing its efficacy in lowering IOP.

## Why Each Wrong Option is Incorrect
- **Option A:** If this option describes a desirable property such as high lipid solubility, cardioselectivity, or a long duration of action, then it is incorrect as an "EXCEPT" option.
- **Option B:** Similarly, if this option also describes a favorable characteristic, it would not be the correct answer to the "EXCEPT" question.
- **Option D:** Likewise, if this option is another beneficial property, it would be incorrect as the answer.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **timolol**, a non-selective beta blocker, is commonly used topically for glaucoma. It is relatively lipophilic, which allows good corneal penetration. **Betaxolol**, on the other hand, is a beta-1 selective (cardioselective) beta blocker with less systemic effects but slightly lower efficacy in lowering IOP due to its lower lipophilicity.

## Correct Answer: B.